Should we bring the wooly mammoth and other species back from extinction — Yes or no?

Credit: Pixabay/ GDJ
Credit: Pixabay/ GDJ

If you had a chance to save a species from extinction, would you take it? I would—and I am.

There are numerous arguments in favor of de-extinction science, but I want to focus on the most pressing one: conservation. Experts predict that the earth could soon lose at least 40 percent of its biodiversity. My colleagues and I often cite a stat from the Harvard biologist E.O. Wilson: that around 30,000 species are disappearing every year, or nearly three per hour. And yet we have the capacity not only to stop extinction but to reverse it. To save the planet’s biodiversity, de-extinction must become Conservation 2.0.

My team and I at Colossal, a de-extinction company and lab, are establishing protocols, partnerships, and programs to create reproducible, affordable, and efficient processes to bring back marsupial, mammal, and avian species.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

De-extinction is that new generation of science that will prove to be the greatest ally of conservation. And it is already happening. In our efforts to de-extinct the woolly mammoth, we have brought together prominent conservation experts, committed funding to end a deadly elephant herpes virus, and supported assisted reproductive technologies for species outside of our immediate purview.

This is an excerpt. Read the full article here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Cancer mRNA Vaccine Concept
'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer
ChatGPT Image Jul 31, 2026, 08_05_37 AM
26% and far worse than during COVID: Under RFK Jr., Americans’ opinion of ‘revamped’ CDC hits an all-time low
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-26-at-11.06.10-AM
Viewpoint: The organic, good-food, small-farm movement is seductive but wrongheaded. Here’s the sustainability and environmental case for industrial farming
Picture1
Viewpoint: How badly is the U.S. food-safety net fraying? FDA’s bungled handling of the tainted lettuce crisis deepens concerns over cuts to disease tracking and response
Healthy Food Sensitivity Test Collection
Viewpoint: That’ll be $300: The wellness industry’s junk science scam to ‘fix’ your immune system that isn’t broken
Screenshot-2026-10-24-121036
Many hospitals embrace longevity medicine. Are they separating science from hype?
Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
China Innovation Lightbulb 2
China’s 5-year plan to accelerate science innovation is putting the U.S. and Europe in the rearview mirror
Screenshot-2026-10-19-at-12.04.51-PM
Victims of their own success: As memories of killer diseases fade, vaccine rejectionism soars
Crimson Drips Over the White House
In Trump administration redirect, U.S. steers NIH sharply away from biodefense and pandemic preparedness
Screenshot-2026-10-23-at-10.37.12-AM
Viewpoint: Drones, dollars and baby food: Critical innovations that anti-plastic ideologues willfully ignore
Strawberry Clamshell with Warning Sticker
Viewpoint: Activists hype ‘dangerous level’ of pesticide residues in Driscoll berries: Separating health concerns from fear-mongering
Diet Soda with Measuring Tape 2
Science challenges anti-soda activists: No, sodas won’t make you fat
Screenshot-2026-10-22-at-12.45.14-PM
Pennsylvania tells doctors to prepare for a surge in newborn measles cases—a complication unseen in decades
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.